Potential anticancer agents. IV. 5-Substituted pyrimidine-6-carboxaldehydes and derivatives.
D000447:Aldehydes / Q000138:chemical synthesis; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D046508:Culture Techniques; D005493:Folic Acid Antagonists; D005561:Formates / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D051379:Mice; D009963:Orotic Acid / Q000378:metabolism; D010649:Phenylalanine / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D011743:Pyrimidines / Q000138:chemical synthesis; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000447:Aldehydes; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D005493:Folic Acid Antagonists; D005561:Formates; D011506:Proteins; D011743:Pyrimidines; D014316:Tritium; D010649:Phenylalanine; D009963:Orotic Acid; D005998:Glycine; D013936:Thymidine